360 likes | 372 Views
Dr. Alan Fong shares a 10-year experience with the Malaysian ACS & PCI Registries and discusses how the data collected has been translated into research and practice. This session will provide valuable insights into addressing the local disease burden and improving therapeutic protocols.
E N D
Joint Meeting of Coronary Revascularisation (JCR), Busan. 9-10 December 2016. Session 5: 1550hrs, Room A 10 Year Experience with the Malaysian ACS & PCI Registries: translation into research and practice Dr Alan Fong MBChB(Bristol), MRCP(UK), FRCP (Edin), FACC, FESC, FAPSIC, FNHAM, FAsCC Consultant Cardiologist, Sarawak General Hospital Heart Centre; & Head, Clinical Research Centre, Sarawak General Hospital Adjunct Professor, Swinburne University of Technology
The NCVD Registries (e.2006) http://www.acrm.org.my/ncvd/aboutUs_overview.php
NCVD PCI Registry Report 2013-2014
Snapshot from the Annual Report of the NCVD-ACS Registry 2011-2013 Suggested citation: W.A. Wan Azman, K.H. Sim. (Eds). Annual Report of the NCVD-ACS Registry, Year 2011-2013. Kuala Lumpur, Malaysia: National Cardiovascular Disease Database, 2015.
NCVD-ACS Registry Participating Hospitals HTF HQEI HQEII HRPZ II HSB HSNZ HPP HRPB HTAA PJHUS UMMC IJN HKL HTAR HS HA Total SDP= 19 hospitals HTJ HSA *Each SDP started to contribute data at different time period HM NCVD-ACS Registry, Malaysia (2011-2013)
Mean age: 58.5 (12.2) years N ACS admissions = 14,763
Hypertension 65% Diabetes 46%
Presence of cumulative risk factors (Percentage), NCVD-ACS Registry, 2011-2013
Type of cardiac presentation for patients with ACS (%) by admission, NCVD-ACS Registry, 2006 - 2013
Age group of patients by ACS stratum NCVD-ACS Registry, 2011-2013 NSTEMI
Type of treatment among STEMI patients by Age Group , NCVD-ACS Registry, 2011-2013
NCVD ACS In-Hospital Mortality and 30-day Follow up: 2006-2010 VS 2011-2013 Outcome at discharge is similar but 30 day outcomes improved significantly
STEMI: comparison between NCVD and TIMI developmental dataset An Asian Validation of the TIMI risk score for ST-Segment Elevation Myocardial Infarction: Results and Implications for Cardiac Care in a Developing Country. Sharmini Selvarajah, Alan Fong Yean Yip, Gunavathy Selvaraj, Jamaiyah Haniff, Cuno S.P.M. Uiterwaal, Michiel L. Bots, PLoS One 2012;7(7):e40249
STEMI reperfusion strategies in UK and Malaysia Malaysia 2013 – approx. 70% lytic, approx 9% PPCI
Summary: how the NCVD has helped us…. • Systematic collection of local data important • Better understanding of the local disease burden • Strategies to improve therapeutic protocols • Addressing the evidence gap by research • Translating research into guidelines